Diagnostic and clinical significance of Crohn’s disease-specific pancreatic anti-GP2 and anti-CUZD1 antibodies

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical Chemistry and Laboratory Medicine

• Publication date

  2016-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1515/cclm-2015-0376PMID 26351932
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Visualization of the entire differentiation process of murine M cells: suppression of their maturation in cecal patches

  2014cited by this paper
• Serological studies in inflammatory bowel disease: how important are they?

  2014cited by this paper
• Crohn’s disease specific pancreatic antibodies: clinical and pathophysiological challenges

  2014cited by this paper
• Towards personalized care in IBD

  2014cited by this paper
• The microbiome in inflammatory bowel disease: current status and the future ahead.

  2014cited by this paper
• The Novel Crohn's Disease Marker Anti-GP2 Antibody Is Associated with Ileocolonic Location of Disease

  2013cited by this paper
• Autoantibodies against exocrine pancreas in Crohn's disease are directed against two antigens: the glycoproteins CUZD1 and GP2.

  2013cited by this paper
• CUZD1 and Anti-CUZD1 Antibodies as Markers of Cancer and Inflammatory Bowel Diseases

  2013cited by this paper
• Glycoprotein 2 antibodies in Crohn's disease.

  2013cited by this paper
• Combined Serological, Genetic, and Inflammatory Markers Differentiate Non-IBD, Crohn's Disease, and Ulcerative Colitis Patients

  2013cited by this paper
• Materials for : Host-microbe interactions shape genetic risk for inflammatory bowel disease

  2012cited by this paper
• Ileal Inflammation May Trigger the Development of GP2-Specific Pancreatic Autoantibodies in Patients with Crohn's Disease

  2012cited by this paper
• Identification of Pancreatic Glycoprotein 2 as an Endogenous Immunomodulator of Innate and Adaptive Immune Responses

  2012cited by this paper
• Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn’s disease

  2012cited by this paper
• Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies.

  2011cited by this paper
• Glycoprotein 2 (GP2)

  2010cited by this paper
• Inflammatory bowel disease.

  2009cited by this paper
• Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn’s disease

  2009cited by this paper
• Uptake through glycoprotein 2 of FimH+ bacteria by M cells initiates mucosal immune response

  2009cited by this paper
• Pancreatic Autoantibodies Are Associated with Reactivity to Microbial Antibodies, Penetrating Disease Behavior, Perianal Disease, and Extraintestinal Manifestations, But Not with NOD2/CARD15 or TLR4 Genotype in a Hungarian IBD Cohort

  2009cited by this paper
• Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies

  2008cited by this paper
• [Molecular basis of antigen transcytosis by specialized epithelial M cells].

  2008cited by this paper
• Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study.

  2007cited by this paper
• Utility of serological markers in inflammatory bowel diseases: gadget or magic?

  2007cited by this paper
• Serologic markers in inflammatory bowel disease.

  2006cited by this paper
• Pancreatic Autoantibodies in Greek Patients with Inflammatory Bowel Disease

  2005cited by this paper
• Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

  2005cited by this paper
• Pancreatic Autoantibodies in Inflammatory Bowel Disease

  2004cited by this paper
• Pancreatic autoantibodies in Crohn's disease: a family study.

  1997cited by this paper
• Impaired pancreatic function in patients with Crohn's disease with and without pancreatic autoantibodies.

  1996cited by this paper
• Classification of inflammatory bowel disease.

  1989cited by this paper
• The Diffusion of Species

  1884cited by this paper

• Application of single-cell sequencing in the study of immune cell infiltration in inflammatory bowel disease and colorectal cancer

  2025cites this paper
• A Multiparametric Method Improves the Serological Characterization of Inflammatory Bowel Diseases: Preliminary Results from a Multicenter Eastern Europe Study

  2024cites this paper
• Recent Trends in Non-Invasive Methods of Diagnosis and Evaluation of Inflammatory Bowel Disease: A Short Review

  2024cites this paper
• Current Approach to Risk Factors and Biomarkers of Intestinal Fibrosis in Inflammatory Bowel Disease

  2024influential citation
• Non-invasive biomarkers in chronic inflammatory bowel disease: State of the art

  2023cites this paper
• Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn's disease: A Systematic Review.

  2021cites this paper
• Pancreatic glycoprotein 2 is a first line of defense for mucosal protection in intestinal inflammation

  2021cites this paper
• Diagnostic and clinical significance of antigen-specific pancreatic antibodies in inflammatory bowel diseases: A meta-analysis

  2020cites this paper
• Serum Biomarkers for Inflammatory Bowel Disease

  2020cites this paper
• Antibodies Against Glycoprotein 2 Are Specific Biomarkers for Pediatric Crohn’s Disease

  2020cites this paper
• The diagnostic and prognostic value of serological markers of inflammatory bowel diseases (a literature review)

  2020cites this paper
• Диагностическая и прогностическая значимость серологических маркеров воспалительных заболеваний кишечника (обзор литературы)

  2020influential citation
• The search for the Holy Grail: autoantigenic targets in primary sclerosing cholangitis associated with disease phenotype and neoplasia

  2020cites this paper
• Rearing Water Treatment Induces Microbial Selection Influencing the Microbiota and Pathogen Associated Transcripts of Cod (Gadus morhua) Larvae

  2018cites this paper
• Investigating the Clinical Validity of CUB and Zona-Pellucida-like Domain-Containing Protein 1 (CUZD1) in Malignant and Non-Malignant Human Diseases

  2018cites this paper
• Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease

  2018cites this paper
• Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis

  2018cites this paper
• From microbiome to infectome in autoimmunity

  2017cites this paper
• Identification of Antibody Against SNRPB, Small Nuclear Ribonucleoprotein-Associated Proteins B and B’, as an Autoantibody Marker in Crohn’s Disease using an Immunoproteomics Approach

  2017cites this paper
• Autoantibodies Against Glycoprotein 2 Isoforms in Pediatric Patients with Inflammatory Bowel Disease

  2017cites this paper
• Mechanisms of Autoantibody-Induced Pathology

  2017cites this paper
• Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseases

  2017cites this paper
• A case report of serum sickness-like syndrome as the first manifestation of i nflammatory bowel disease IBD

  2017cites this paper
• Generation of monoclonal antibodies and development of an immunofluorometric assay for the detection of CUZD1 in tissues and biological fluids.

  2017cites this paper
• Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience

  2017cites this paper
• Diagnostic value of the antiglycoprotein-2 antibody for Crohn’s disease: a PRISMA-compliant systematic review and meta-analysis

  2017cites this paper
• Autoimmunity in Crohn's Disease-A Putative Stratification Factor of the Clinical Phenotype.

  2016cites this paper
• Serologic Anti-GP2 Antibodies Are Associated with Genetic Polymorphisms, Fibrostenosis, and Need for Surgical Resection in Crohn's Disease

  2016cites this paper
• Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy

  2016cites this paper
• World Journal of Gastrointestinal Oncology

  year unknowncites this paper